.png)
ELSABAGH SCORING SYSTEM FOR ASSESSING SEVERITY AND TREATMENT IMPROVEMENT IN MULTIPLE ORAL LICHEN PLANUS
Abstract
Introduction: Lichen planus (LP) is a mucocutaneous, chronic, autoimmune disease, with various clinical manifestations, often involving the oral mucosa, and commonly occurs in adults 30-60 years old. Among the various scoring systems for oral lichen planus, the Elsabagh scoring system is valid, accurate, relatively easier to teach, relatively faster to master, and does not require complex calculations.
Objective: This paper aimed to report and evaluate the successful therapy given based on using the Elsabagh scoring system in oral lichen planus. Case: A 53-years-old woman came to the Department of Oral Medicine with a main complaint of pain in the upper gums and lower right left a year ago. The pain got worse when eating highly spiced and spicy foods. She felt pain when brushing her teeth. Extra oral examination revealed multiple white plaques on the vermilion border. Intra-oral examination revealed erosive, erythema, accompanied by white plaques mesh-like shaped, irregular, and painful, on the upper labial, right and left buccal mucosa, posterior teeth of the mandible that extend into the mucobuccal fold, and gingiva, palate, and posterior gingiva of the right and left maxillae. Amalgam fillings were found on teeth 37 and 46 with plaque and calculus. Based on clinical features, the patient was diagnosed with Multiple Oral Lichen Planus of Erosive and Reticular type. Case management: The patient received topical and systemic corticosteroids, mouthwashes, and supplements. She was advised to stop eating highly spiced and spicy foods, replace amalgam filling with tooth-colored filling, scaling, and replace removable dentures with permanent dentures. The evaluation result using the Elsabagh scoring system showed an improvement from the value of 8 on the initial visit to 3 on the last visit. There was an improvement in the patient's condition after treatment based on evaluation using the Elsabagh scoring system in this case. The Elsabagh scoring system can correlate disease severity with subjective symptoms, allowing comparisons between the initial evaluation of lesions and treatment efficacy or disease progression in oral lichen planus.
Keywords: Autoimmune, Elsabagh Scoring System, Oral Lichen Planus
Full Text:
PDFReferences
Maheswari TNU, Chaudhary M. Management of oral lichen planus based on the existing clinical practice guidelines. J Indian Acad Oral Med Radiol. 2020;32(3):284–92.
Gorouhi F, Davari P, Fazel N. Cutaneous and mucosal lichen planus: A comprehensive review of clinical subtypes, risk factors, diagnosis, and prognosis. Sci World J. 2014;2014:1–22.
Vičić M, Hlača N, Kaštelan M, Brajac I, Sotošek V, Prpić Massari L. Comprehensive Insight into Lichen Planus Immunopathogenesis. Int J Mol Sci. 2023;24(3):1–16.
Gall R, Navarro-Fernandez IN. Lichen Planus Erosive Form [Internet]. StatPearls. Treasure Islands: StatPearls Publishing LLC.; 2023. 1–6 p. Available from: http://www.ncbi.nlm.nih.gov/pubmed/32809535
Gangeshetty N. Oral lichenplanus: Etiology, pathogenesis, diagnosis, and management. World J Stomatol. 2015;4(1):12.
Gobbo M, Rupel K, Zoi V, Perinetti G, Ottaviani G, Di Lenarda R, et al. Scoring systems for oral lichen planus used by differently experienced raters. Med Oral Patol Oral Cir Bucal. 2017;22(5):e562–71.
Michael Glick, Martin S. Greenberg, Peter B. Lockhart SJC. Burket’s Oral Medicine. 13th ed. USA: John Wiley and Sons, Inc.; 2021. 106–115; 437–439 p.
Unnikrishnan SP, Rampersaud E, Mcgee A, Cruickshank ME, Abu-Eid R, Hijazi K. Disease severity scoring systems in mucosal lichen planus: A systematic review. Oral Dis. 2022;(November):1–16.
Elsabagh HH, Gaweesh YY, Ghonima JK, Gebril M. A novel comprehensive scoring system for oral lichen planus: A validity, diagnostic accuracy, and clinical sensitivity study. Oral Surg Oral Med Oral Pathol Oral Radiol [Internet]. 2021;131(3):304–11. Available from: https://doi.org/10.1016/j.oooo.2020.12.016
Dydyk AM, Gandhe S. Pain Assessment. In: NCBI Bookshelf [Internet]. Treasure Islands: Elsevier; 2023. p. 1–8. Available from: http://creativecommons.org/licenses/by-nc-nd/4.0/
Deng X, Wang Y, Jiang L, Li J, Chen Q. Updates on immunological mechanistic insights and targeting of the oral lichen planus microenvironment. Front Immunol. 2023;13(January):1–16.
Rotaru D, Chisnoiu R, Picos A, Picos A, Chisnoiu A. Treatment trends in oral lichen planus and oral lichenoid lesions (Review). Exp Ther Med. 2020;20(6):1–5.
Chaitanya, Nallan CSK; Chintada, Suvarna; Kandi, Pallavi; Kanikella, Sushma; Kammari, Anuja; Waghamare RS. Zinc Therapy in Treatment of Symptomatic Oral Lichen Planus. Indian Dermatol Online J. 2019;10(2):174–7.
Campana F, Lan R, Girard C, Rochefort J, Le Pelletier F, Leroux-Villet C, et al. French guidelines for the management of oral lichen planus (excluding pharmacological therapy). Ann Dermatol Venereol [Internet]. 2022;149(1):14–27. Available from: https://doi.org/10.1016/j.annder.2021.04.003
Motahari P, Pournaghi Azar F, Rasi A. Role of Vitamin D and Vitamin D Receptor in Oral Lichen Planus: A Systematic Review. Ethiop J Health Sci. 2020;30(4):615–22.
Filla JB, Fontanelli A, Brown MA, Angela M, Machado N. Treatment of symptomatic oral lichen planus : a literature review Leczenie objawowego liszaja płaskiego jamy ustnej : przegląd literatury. Pol PRZEGLĄD OTORYNOLARYNGOLOGICZNY, TOM. 2016;5(1):s. 30-35.
Chen HX, Blasiak R, Kim E, Padilla R, Culton DA. Triggers of oral lichen planus flares and the potential role of trigger avoidance in disease management. Oral Surg Oral Med Oral Pathol Oral Radiol [Internet]. 2017;124(3):248–52. Available from: http://dx.doi.org/10.1016/j.oooo.2017.05.508
Samuel S, Nguyen T, Choi HA. Pharmacologic Characteristics of Corticosteroids. 2017;10(2):53–9.
Bagan J, Paderni C, Termine N, Campisi G, Lo Russo L, Compilato D, et al. Mucoadhesive Polymers for Oral Transmucosal Drug Delivery: A Review. Curr Pharm Des. 2012;18(34):5497–514.
Golshani S, Vatanara A, Amin M. Recent Advances in Oral Mucoadhesive Drug Delivery. J Pharm Pharm Sci. 2022;25:201–17.
Mehta AB, Nadkarni NJ, Patil SP, Godse K V., Gautam M, Agarwal S. Topical corticosteroids in dermatology. Indian J Dermatol Venereol Leprol. 2016;82(4):371–8.
Camisa C, Garofola C. Topical Corticosteroids. Compr Dermatologic Drug Ther Fourth Ed. 2020;511-527.e6.
Sidhu G, Preuss C V. Triamcinolone. In: NCBI Bookshelf. Treasure Islands: StatPearls Publishing LLC.; 2023. p. 1–5.
Marijanović I. Use of the Depression, Anxiety, and Stress Scale ( DASS-21 ) Questionnaire to Assess Levels of Depression, Anxiety, and Stress in Healthcare and Administrative Staff in 5 Oncology Institutions in Bosnia and Herzegovina During the 2020 COVID-19 Pandemic. Med Sci Monit. 2021;27:1–9.
DOI: http://dx.doi.org/10.20527/dentino.v9i1.18866
DOI (PDF): http://dx.doi.org/10.20527/dentino.v9i1.18866.g9879
Article Metrics
Abstract view : 187 timesPDF - 160 times
Refbacks
- There are currently no refbacks.
Contact Us:
Faculty of Dentistry
Lambung Mangkurat University
Jalan Veteran No. 128 B Banjarmasin, Indonesia
E-mail. [email protected]
Website. fkg.ulm.ac.id
This work is licensed under a Creative Commons Attribution 4.0 International License.